Skip to content
          • Log In
      Drug Discovery World (DDW)Drug Discovery World (DDW)
        • E-news Sign Up
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
          Drug Discovery World (DDW) Menu   ≡ ╳
          • Home
          • News
          • DDW Exclusive Content
          • COVID-19
          • Opinion
          • Business
          • Regulatory
          • Intelligence

              Categories

              Latest Industry Intelligence

              Trends & Analysis
              Market Reports
              Whitepapers & App notes
              eBooks
              Start-up Zone Archive
              Events
              DDW exclusive ebook: AI in drug discovery

              AI in drug discovery eBook out now   This 28-page DDW eBook, sponsored by Benchling, contains [...]

              Global pharma start-up success stories

              From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups [...]

              AI Vaccines Drug Discovery Data
          • Cancer Research
          • Webinars
          • Podcasts
          • Archive
            • –
              • 2000 Archive
              • 2001 Archive
              • 2002 Archive
              • 2003 Archive
              • 2004 Archive
              • 2005 Archive
              • 2006 Archive
            • –
              • 2007 Archive
              • 2008 Archive
              • 2009 Archive
              • 2010 Archive
              • 2011 Archive
              • 2012 Archive
              • 2013 Archive
            • –
              • 2014 Archive
              • 2015 Archive
              • 2016 Archive
              • 2017 Archive
              • 2018 Archive
              • 2019 Archive
          • Videos

        • Sidebar Banner 6

        • Sidebar Banner 7

        • Sidebar Banner 8

        • Sidebar Banner 12

        • Sidebar Banner 18

        • Sidebar Banner 19

        • Sidebar Banner 20

        • Sidebar Banner 21

        Back in-person for 2022: LSX World Congress returns

        4 May 2022

        For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London.   The event gathers the founders and CEOs of innovative […]

        PerkinElmer expands in vivo instruments portfolio  

        19 April 2022

        PerkinElmer has expanded its in vivo imaging portfolio with the launch of the Vega imaging system, an ultrasound platform that combines hands-free, automated technology with high-throughput capability to accelerate non-invasive research and drug development studies of cancer, liver and kidney disease, cardiology and more.   The Vega system   The system eliminates challenges associated with conventional hand-held […]

        Novel drug effective in a mouse model of Alzheimer’s disease

        13 April 2022

        Neuro-Bio, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, has found its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease. Publishing their work in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), Neuro-Bio researchers, in collaboration with the drug discovery company Evotec SE, UCLA, […]

        Lonza expands to enable efficient humanised mouse model development

        13 April 2022

        Lonza has expanded its human stem cell offerings to provide human cord blood CD34+ haematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a rapidly expanding market need.  CB-CD34+ HSCs are the preferred cell choice for creating humanised mouse models, which are critical for preclinical safety testing of a range of immunotherapies. The new […]

        C2i Genomics launches AI-powered cancer monitoring tests in Europe 

        13 April 2022

        C2i Genomics, a cancer intelligence company, has launched its C2inform minimal residual disease (MRD) test across Europe after obtaining CE-IVD marking in the EU, UK and Switzerland.   The company also announced the completion of several clinical trials across the globe, including cancer centers in Europe, US and Singapore.   The new clinical data will be presented […]

        PerkinElmer releases assay kits for more effective biotherapeutics 

        12 April 2022

        PerkinElmer has announced two ready-to-use HTRF and AlphaLISA no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during biopharmaceutical manufacturing.   Recombinant therapeutic proteins, such as monoclonal antibodies, some vaccines and other biologics, must be free of residual host cell protein (HCP) impurities to prevent immunogenicity or reduced potency, stability or […]

        Interview: 17-year-old invents life-saving gel technology  

        11 April 2022

        When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last year. DDW’s Megan Thomas caught […]

        First volunteers dosed with psychedelics in clinical trial 

        11 April 2022

        Beckley Psytech, a company addressing neurological and psychiatric disorders through the application of psychedelic medicines, announced that the first healthy volunteers have been dosed in a Phase I clinical trial exploring the safety and pharmacokinetics of BPL-003, Beckley Psytech’s second formulation of 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT).  The study  The Phase I study is designed as a […]

        This week in drug discovery (4-8 April) 

        8 April 2022

        News round-up by DDW’s Megan Thomas for 4-8 April   When considering trends in the drug discovery industry, the use of technology to advance treatments and therapeutics is consistently observed. DDW rounds up five of this week’s top news stories which reveal this theme of technology, AI and biotechnology.   1. Jumpcode Genomics launches tech to improve […]

        Comment: Innovations for tomorrow’s drug discovery 

        8 April 2022

        At the end of last month, DDW’s Megan Thomas attended ELRIG’s Research & Innovation 2022: Innovations for Tomorrow’s Drug Discovery, at The King’s Centre in Oxford, UK. The four sessions addressed aspects of innovation across drug discovery and placed an emphasis on both the digital age and novel modalities: Omics technology innovations; The future of […]

        • 1
        • 2
        • 3
        • 4
        • …
        • 124
        Next »
        Sidebar Banner 1

        Sidebar Banner 2

        Sidebar Banner 3

        Sidebar Banner 4

        Sidebar Banner 9

        Sidebar Banner 10

        Sidebar Banner 11

        Sidebar Banner 13

        Sidebar Banner 14

        Sidebar Banner 15

        Sidebar Banner 16

        Sidebar Banner 17

          • Contact Us
          • About Us
          • Subscribe FREE
          • Media Info
          • E-news Sign Up
          • Log In
          • Terms and Conditions
          • Privacy Policy

        Follow our social accounts

             

        Copyright 2022 © Drug Discovery World (DDW). All Rights Reserved

        Designed & Developed with ❤ for digital by Inbound FinTech

        • Home
        • News
        • DDW Exclusive Content
        • COVID-19
        • Opinion
        • Business
        • Regulatory
        • Intelligence
          • Trends & Analysis
          • Market Reports
          • Whitepapers
          • Start-up Zone
          • Events
        • Cancer Research
        • Webinars
        • Podcasts
        • Archive
        • Videos
        • E-news Sign Up
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
            • Log In